One reason could be the limited dynamic range of LDH values in the serum of cancer patients which encompasses approximately one order of magnitude whereas S100B in the serum of melanoma patients ranges from below 0.11 μg/L to levels above 10.0 μg/L, suggesting a significantly greater sensitivity. The gene discussed is S100B; the disease is melanoma.